Search News:
Year
Latest
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
1
10.03.2026
Notification the exercise of DEMCO-W8
2
27.02.2026
The determination of the date for the 2026 Annual General Meeting of Shareholders, the omission of dividend payments and the appointment of new directors
3
27.02.2026
Management Discussion and Analysis Yearly Ending 31 Dec 2025
4
27.02.2026
Financial Performance Yearly (F45) (Reviewed)
5
27.02.2026
Financial Statement Yearly 2025 (Audited)
6
13.01.2026
New shares of DEMCO to be traded on January 14, 2026
7
12.01.2026
The result to propose Director Nominate, Agenda and Questions for the 2026 Annual General Meeting of Shareholder.
8
09.01.2026
Notification for registration of increase in paid-up capital of the Company
9
09.01.2026
Report on the results of the Exercise of DEMCO-W8 (F53-5) (Revised)
10
09.01.2026
Report on the results of the Exercise of DEMCO-W8 (F53-5)
11
06.01.2026
Notification of change in Management Structure and Senior Management (Revised)
12
06.01.2026
Notification of change in Management Structure and Senior Management
13
08.12.2025
Notification the exercise of DEMCO-W8
14
08.12.2025
Notification of the details for those paying attention to Exercise The Warrants to Purchase Ordinary Shares of DEMCO Public Company Limited according to the Warrants "DEMCO-W8" (1st exercise)
15
03.12.2025
Information Memorandum Description, Conditions, Key Features of the Warrants to Purchase the newly Issued Ordinary Shares of DEMCO Public Company Limited No. 8 (DEMCO-W8)
16
03.12.2025
SET adds new listed securities : DEMCO-W8 to be traded on December 4, 2025
17
21.11.2025
Report on the results of the sale of warrants offered to Common shares' shareholders via Preferential Public Offering (PPO) (F53-5)
18
21.11.2025
Issuance Date of the Warrants to Purchase Newly Issued Ordinary Shares of DEMCO Public Company Limited No.8 (DEMCO-W8)
19
14.11.2025
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025
20
14.11.2025
Financial Performance Quarter 3 (F45) (Reviewed)